메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
저널정보
대한안과학회 Korean Journal of Ophthalmology Korean Journal of Ophthalmology 제34권 제1호
발행연도
2020.1
수록면
11 - 18 (8page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Purpose: To investigate the effect of intravitreal anti-vascular endothelial growth factor (VEGF) injections onganglion cell-inner plexiform layer (GCIPL) thickness in patients with age-related macular degeneration (AMD). Methods: This retrospective study included patients with continuous anti-VEGF treatment who were administeredat least three consecutive injections for unilateral neovascular AMD. The GCIPL thickness of the studyeyes was compared before and after treatment and with healthy fellow eyes using spectral-domain opticalcoherence tomography. We also evaluated best-corrected visual acuity, age, and intraocular pressure. Results: In total, 96 eyes of 48 patients (14 females and 34 males; mean ± standard deviation [SD] age, 70.10 ±8.89 years) with mean number of 6.29 (SD ± 3.76) anti-VEGF injections and a mean follow-up period of 24.93months (SD ± 19.86) were included in the study. After three consecutive intravitreal injections of anti-VEGF, themean GCIPL thickness was significantly reduced from 70.50 (SD ± 14.06) to 65.97 (SD ± 13.91) μm. Borderlineor nonsignificant decrease was also observed in GCIPL thickness for each sector. At the end of the study, themean GCIPL thickness was further reduced to 62.56 (SD ± 16.30) μm, and significant decreases were alsoobserved in all other sectors compared with baseline. Conclusions: It has been observed that GCIPL thickness can decrease with only three consecutive anti-VEGFinjections as well as with long-term treatment in AMD patients.

목차

등록된 정보가 없습니다.

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0